Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis

Ranu Baral, Maddie White, Vassilios S Vassiliou
doi: https://doi.org/10.1101/2020.05.03.20089375

Article usage

Article usage: May 2020 to August 2025

AbstractFullPdf
May 202017800480
Jun 20205740103
Jul 2020274066
Aug 2020256073
Sep 202089031
Oct 202064023
Nov 202086023
Dec 202062028
Jan 202154311
Feb 202155015
Mar 202152212
Apr 20216307
May 202158215
Jun 202163518
Jul 202151118
Aug 202163527
Sep 202142017
Oct 202144225
Nov 202148425
Dec 20213713
Jan 20223294
Feb 20223808
Mar 20223718
Apr 20223636
May 202232110
Jun 20222805
Jul 20223802
Aug 20222715
Sep 202233111
Oct 20222608
Nov 20221905
Dec 20221716
Jan 20232307
Feb 20231428
Mar 20231403
Apr 20232215
May 20231829
Jun 20231148
Jul 2023804
Aug 202319136
Sep 20231764
Oct 20231403
Nov 20231341
Dec 20231513
Jan 20241324
Feb 2024902
Mar 20241023
Apr 2024934
May 2024803
Jun 20241445
Jul 202414013
Aug 20241745
Sep 20241515
Oct 20241115
Nov 20241016
Dec 20241318
Jan 202514312
Feb 20251457
Mar 202524117
Apr 20251784
May 20251373
Jun 202527710
Jul 202518108
Aug 2025526
Back to top
Posted May 08, 2020.
Download PDF
Data/Code
Email
Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis
Ranu Baral, Maddie White, Vassilios S Vassiliou
medRxiv 2020.05.03.20089375; doi: https://doi.org/10.1101/2020.05.03.20089375
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area